Healthcare+ Expo Taiwan: Advancing Global Cancer Detection with OkaiDx™

Horizontal cover image of Alijie Biotech exhibiting at the 2025 Taiwan Healthcare+ Expo.
Transforming Cancer Care Through Innovation
  • Early Cancer Detection & Monitoring Platform, built on non-invasive multi-cancer detection using DNA methylation and multi-biomarker analysis, our goal is to provide clinical opportunities to identify diseases at their earliest stages—”before symptoms even appear.
  • International CAP/CLIA Certified Clinical Laboratory Platform Through our own CAP-accredited and CLIA-certified central laboratory in the United States, we provide high-quality testing services. We offer a robust platform for collaboration with medical institutions, research teams, and industry partners to support international clinical needs.
EG BioMed CSO and TMU Professor Ruo-Kai Lin demonstrating precision healthcare services at the Healthcare+ Expo Taiwan.
EG BioMed CSO and TMU Professor Ruo-Kai Lin demonstrating precision healthcare services at the Healthcare+ Expo Taiwan.
A Growing Global Footprint

The 9th Healthcare+ Expo Taiwan served as a pivotal platform for our international expansion. We were honored to connect with distributors across Asia and the Middle East, as well as key leaders from major hospitals and healthcare systems.

These global discussions reinforce the surging demand for accessible, high-accuracy, and early cancer detection solutions. They also highlight the critical role our U.S.-based laboratory plays in supporting global clinical testing requirements.

Looking Ahead

Together with our partners worldwide, we continue to expand the reach of OkaiDx™, advancing early detection and treatment monitoring for patients everywhere.

The expo may have concluded, but our collaboration is just beginning. If you are interested in exploring partnership models, international testing services, or our latest technological advancements, we invite you to contact us directly.

EG BioMed — Empowering Global Health through Precision Detection.

Leave a Reply

Discover more from EG BioMed

Subscribe now to keep reading and get access to the full archive.

Continue reading